DOJ Launches West Coast Health Care Fraud Strike Force: Implications for Telehealth, Behavioral Health, and Specialty Pharmacy Companies

The U.S. Department of Justice (DOJ) recently announced the launch of a new West Coast Health Care Fraud Strike Force, a coordinated initiative bringing together prosecutors from DOJ’s Health Care Fraud Unit, U.S. Attorneys’ Offices, and enforcement partners including the Federal Bureau of Investigation (FBI), Department of Health and Human Services (HHS) Office of Inspector General (OIG), and Drug Enforcement Administration (DEA) to investigate and prosecute health care fraud across Arizona, Nevada, and Northern California.

Although the announcement is framed as a regional expansion of existing enforcement efforts, it likely reflects a broader trend in DOJ enforcement priorities. DOJ emphasized a coordinated, data-driven approach designed to identify and pursue increasingly sophisticated health care fraud schemes, particularly those involving technology-enabled care delivery models and evolving reimbursement structures.

For organizations operating in the telehealth, behavioral health, and specialty pharmacy spaces, the announcement is noteworthy because it suggests continued movement toward proactive identification of billing patterns, utilization trends, and operational relationships rather than reliance solely on traditional complaints or whistleblower allegations. DOJ's announcement and related statements identify several key areas likely to remain enforcement priorities:

• Telehealth and technology-enabled fraud schemes, including arrangements involving remote care models and technology platforms;
• Behavioral health and substance use treatment arrangements, an area that has seen substantial federal enforcement activity in recent years;
• Medicare and Medicaid fraud schemes, including fraudulent billing practices and reimbursement-related misconduct;
• Durable medical equipment (DME) and related health care product schemes; and
• Data-driven detection of emerging fraud patterns, including the use of analytics to identify abnormal billing and utilization trends.

For many organizations, the significance of these priorities extends beyond the specific conduct DOJ identifies. Increasingly, regulators appear willing to examine not only whether services were appropriately provided and billed, but also the broader business and operational structures supporting care delivery.

For example, telehealth companies have seen heightened scrutiny surrounding patient acquisition strategies, marketing relationships, and arrangements that may create perceived incentives affecting clinical decision making. Behavioral health organizations continue to face significant oversight concerning referral relationships and financial arrangements, particularly in the substance use disorder treatment space. Specialty pharmacies and related service providers may encounter similar questions where complex operational models involve multiple parties participating in patient support, reimbursement, or care coordination activities.

Perhaps the most important takeaway from DOJ's announcement is its emphasis on analytics and coordinated enforcement efforts. Historically, organizations often viewed compliance through a reactive lens focused on audits, investigations, or isolated allegations. The Strike Force model reflects a different approach: identifying patterns and outliers before concerns are raised externally.

Organizations may wish to take this opportunity to revisit existing compliance structures and business practices, particularly where operations involve:

• Technology-enabled care delivery models;
• Third-party marketing, patient acquisition, or referral arrangements; and
• Complex financial or operational relationships among providers, pharmacies, vendors, and affiliated entities.

The launch of the West Coast Strike Force likely signals continued expansion of DOJ's focus on modern health care delivery models. Companies operating in telehealth, behavioral health, specialty pharmacy, and related sectors should anticipate increased scrutiny not simply regarding what services are provided, but how those services are delivered and supported operationally.

Quarles will continue to monitor these developments and their implications for health care organizations operating across these sectors. If you have questions, please contact your Quarles attorney or:

• Eric Pruitt: (312) 715-5170 / eric.pruitt@quarles.com
• Nick Meza: (602) 229-5439 / nicholas.meza@quarles.com
• Simone Colgan Dunlap: (602) 229-5510 / simone.colgandunlap@quarles.com